RECRUITING

Blood Flow Restriction & Tennis Elbow Rehab

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Lateral epicondylitis (LE), often referred to as "tennis elbow" is a common and debilitating overuse injury affecting 1-3% of adults annually. LE is most often defined as a syndrome of pain near the area of the lateral epicondyle of the elbow commonly effecting the origin of the extensor carpi radialis brevis with associated weakness; it most commonly effects the dominant arm. The best treatment for LE is unknown and research to support current treatment methods are insufficient. A common limitation in functional recovery experienced by this population is pain at the lateral aspect of the elbow. As such, innovative therapeutic interventions directed at quickly reducing pain may address this unmet need and allow for improved outcomes, as well as earlier return to function.

Official Title

Blood Flow Restricted Training to Enhance Lateral Epicondylitis Rehabilitation.

Quick Facts

Study Start:2022-05-20
Study Completion:2025-04-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05237869

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 65 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Ages 18-65 years of age
  2. 2. Diagnosis of lateral epicondylitis confirmed by the treating orthopaedic surgeon and ultrasound
  3. 3. Must be able to read and write in English
  4. 4. Able to provide own written consent
  1. 1. Patients over 65 years of age
  2. 2. Contralateral upper extremity involvement resulting in less than normal range of motion, muscle strength or daily pain greater than 1/10
  3. 3. History of prior injection for treatment of lateral epicondylitis
  4. 4. Pregnancy
  5. 5. Recent history of deep venous thrombosis (within the past 12 months)
  6. 6. Active treatment with anticoagulants
  7. 7. History of upper quadrant lymph node dissection
  8. 8. History of endothelial dysfunction
  9. 9. Patient history of easy bruising
  10. 10. Active infection in the injured arm
  11. 11. Cancer
  12. 12. Uncontrolled peripheral vascular disease
  13. 13. Uncontrolled diabetes mellitus

Contacts and Locations

Study Contact

Vicki Jones, MEd, CCRP
CONTACT
5738827583
jonesvicki@health.missouri.edu

Principal Investigator

Julia Nuelle, MD
PRINCIPAL_INVESTIGATOR
University of Missouri Department of Orthopaedic Surgery

Study Locations (Sites)

Vicki Jones
Columbia, Missouri, 65212
United States

Collaborators and Investigators

Sponsor: Julie Nuelle

  • Julia Nuelle, MD, PRINCIPAL_INVESTIGATOR, University of Missouri Department of Orthopaedic Surgery

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-05-20
Study Completion Date2025-04-01

Study Record Updates

Study Start Date2022-05-20
Study Completion Date2025-04-01

Terms related to this study

Additional Relevant MeSH Terms

  • Lateral Epicondylitis